111 related articles for article (PubMed ID: 6697877)
1. An in vivo single- and multiple-dose study of several marketed brands of conventional and controlled-release theophylline.
Kotzan JA; Vallner JV; Stewart JT; Honigberg IL; Brown WJ
Drug Intell Clin Pharm; 1984 Feb; 18(2):147-53. PubMed ID: 6697877
[TBL] [Abstract][Full Text] [Related]
2. A multiple-dose study of sustained-release theophylline and aminophylline.
Meyer MC; Straughn AB; Lieberman P
Chest; 1980 Aug; 78(2):300-3. PubMed ID: 7398417
[TBL] [Abstract][Full Text] [Related]
3. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
4. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of a sustained-release dyphylline formulation.
Simons KJ; Simons FE; Bierman CW
J Clin Pharmacol; 1977 Apr; 17(4):237-41. PubMed ID: 849997
[TBL] [Abstract][Full Text] [Related]
7. Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man.
Sharma PL; Sharma RM
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):394-6. PubMed ID: 583044
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
9. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
10. Comparative bioavailability of two sustained-release theophylline formulations in the dog.
Mengozzi G; Intorre L; Bertini S; Giorgi M; Soldani G
Pharmacol Res; 1998 Dec; 38(6):481-5. PubMed ID: 9990658
[TBL] [Abstract][Full Text] [Related]
11. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
Leeds NH; Gal P; Purohit AA; Walter JB
J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.
Tulain U; Ur-Rahman N
Pak J Pharm Sci; 2008 Apr; 21(2):131-8. PubMed ID: 18390443
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic analysis of sustained-release dosage forms of theophylline in humans: comparison of single and multiple dose studies.
Hussein Z; Bialer M; Friedman M; Raz I
Biopharm Drug Dispos; 1987; 8(5):427-35. PubMed ID: 3663879
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of the pharmacokinetics and urinary metabolites of sustained-release theophylline syrup, granule and tablet preparations].
Horiuchi Y; Takemura T; Ueno K
Arerugi; 1991 Sep; 40(9):1186-93. PubMed ID: 1958133
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new sustained-release theophylline tablet for children.
Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
[TBL] [Abstract][Full Text] [Related]
16. High-pressure liquid chromatographic assay of theophylline in dog feces following oral administration of sustained-release products.
Chow AT; Meek PD; Jusko WJ
J Pharm Sci; 1993 Sep; 82(9):956-8. PubMed ID: 8229696
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the absorption from some commercial enteric-release theophylline products.
Upton RA; Powell JR; Guentert TW; Thiercelin JF; Sansom L; Coates PE; Riegelman S
J Pharmacokinet Biopharm; 1980 Apr; 8(2):151-64. PubMed ID: 7431220
[TBL] [Abstract][Full Text] [Related]
18. [A comparative study of the pharmacokinetics of oral preparations of theophylline].
Tsoĭ AN; Gneushev ET; Maĭorova EM; Gavrilenko LN; Kunes VG
Farmakol Toksikol; 1990; 53(5):39-42. PubMed ID: 2253747
[TBL] [Abstract][Full Text] [Related]
19. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
Contreras J; Pérez N; González R; Ontivero E; López M
Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
Bach JE; Kukanich B; Papich MG; McKiernan BC
J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
